pembrolizumab

…therapies, such as nivolumab and pembrolizumab, have proven beneficial in patients with melanoma and certain other cancer types.

as ipilimumab, nivolumab, and pembrolizumab—were also developed. These therapies, though they were associated with potentially dangerous side effects, were especially effective in mobilizing immune cells to fight tumors. American immunologist James P. Allison and Japanese immunologist Tasuku Honjo were awarded the 2018 Nobel Prize in Physiology or Medicine for…